/*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} Problem 63 . Platelet inhibitors, such as c... [FREE SOLUTION] | 91影视

91影视

. Platelet inhibitors, such as clopidogrel (Plavix) are used to prevent or reduce the frequency of: 1\. hemorrhage associated with hemophilia. 2\. transient ischemia attacks (TIA), strokes, and myocardial infarctions (MI). 3\. subcutaneous ecchymosis. 4\. petechia associated with idiopathic thrombocytopenia purpura.

Short Answer

Expert verified
Option 2: transient ischemia attacks (TIA), strokes, and myocardial infarctions (MI).

Step by step solution

01

Understanding Platelet Inhibitors

Platelet inhibitors like clopidogrel (Plavix) prevent platelets in the blood from clumping together to form clots. These medications are primarily used to prevent health issues that occur when blood flow to certain parts of the body is reduced or obstructed.
02

Assessing Potential Uses

Examine each option to determine if it is associated with platelet inhibitor use: 1. hemorrhage with hemophilia requires treatment to stop bleeding, not prevent clotting. 2. TIA, strokes, and MI occur due to blood clots restricting blood flow, meaning platelet inhibitors are useful. 3. Subcutaneous ecchymosis is a minor bleeding under the skin not typically prevented by these inhibitors. 4. Petechia with idiopathic thrombocytopenia purpura involves low platelet count; thus, prevention with inhibitors isn't logical.
03

Choosing the Correct Option

Based on the analyzed uses, option 2 (prevention of TIA, strokes, and myocardial infarctions) is the only one that fits the typical use of platelet inhibitors which aim to prevent clots that can lead to these conditions.

Unlock Step-by-Step Solutions & Ace Your Exams!

  • Full Textbook Solutions

    Get detailed explanations and key concepts

  • Unlimited Al creation

    Al flashcards, explanations, exams and more...

  • Ads-free access

    To over 500 millions flashcards

  • Money-back guarantee

    We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91影视!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Platelet Inhibitors
Platelet inhibitors are vital medications designed to prevent blood platelets from clumping together and forming clots. When blood flow is obstructed due to clots, it can lead to serious medical conditions such as heart attacks or strokes. These inhibitors are essential in managing and reducing the risk of such events, particularly in individuals with a high risk of clot formation. Clopidogrel, commonly known by its brand name Plavix, is an example of a platelet inhibitor widely used in clinical practice.
Although very effective in preventing dangerous clots, platelet inhibitors also have side effects. They can increase the risk of bleeding as they inhibit the blood's ability to form clots. This means that while you're decreasing the risk of one type of cardiovascular event, you have to be mindful of the potential for bleeding complications.
Clopidogrel Mechanism
Clopidogrel works by interfering with a specific receptor on the surface of platelets known as the P2Y12 ADP receptor. This receptor plays a key role in the process that allows platelets to stick together and form a clot.
By blocking this receptor, clopidogrel prevents the chain reaction required for platelets to clump. This action helps reduce the risk of events like strokes and heart attacks, which are often caused by blood clots.
Importantly, clopidogrel鈥檚 effects are irreversible on the platelets it affects, meaning those platelets stay inactive for their lifetime, typically around 7 to 10 days. This makes regular monitoring and dosing crucial to maintain therapeutic benefits while minimizing risks.
Patient Assessment Skills
Assessing a patient on clopidogrel therapy involves several steps to ensure safe and effective use.
  • Medical History: Start with a thorough review of the patient鈥檚 medical background, focusing on any past episodes of bleeding or clotting disorders. This helps tailor therapy to individual needs.
  • Medication Review: Understanding all medications the patient is taking, including over-the-counter drugs, as interactions can affect clopidogrel's efficacy and safety.
  • Observation: Look for signs of unusual bleeding, such as bruising or prolonged bleeding from cuts. This can indicate that the medication is impacting platelet function too much.
  • Lab Tests: Occasionally, doctors may order blood tests to check platelet activity or to screen for genetic variations that can affect drug metabolism.

These skills help healthcare providers make informed decisions regarding the continuation or adjustment of clopidogrel therapy.
Clinical Decision Making
Clinical decision making with therapies like clopidogrel involves balancing the benefits and risks, guided by evidence-based protocols. It is a dynamic process requiring collaboration and communication among healthcare team members.
The key steps involve:
  • Risk Assessment: Evaluate the risk factors for clotting versus bleeding for each individual. This helps determine the appropriateness of continuing, starting, or discontinuing treatment.
  • Treatment Goals: Align the use of clopidogrel with the patient鈥檚 overall treatment goals, such as reducing the incidence of heart attacks or strokes.
  • Patient Preferences: Consider the patient鈥檚 lifestyle and preferences, ensuring they are informed about their options and any potential side effects.
  • Ongoing Monitoring: Regular follow-up is essential to assess the effectiveness of treatment, manage side effects, and make adjustments as needed.

This informed process improves patient outcomes and promotes safe medication use, ultimately supporting positive healthcare results.

One App. One Place for Learning.

All the tools & learning materials you need for study success - in one app.

Get started for free

Most popular questions from this chapter

. A diabetic patient calls your clinic and reports her insulin is 鈥渃lumpy.鈥 You advise her to: 1\. shake the vial vigorously to re-suspend the insulin particles. 2\. warm the vial to room temperature to see whether the clumps disappear. 3\. discard the vial and open a new one. 4\. gently roll the vial between her hands to re-warm the solution and re- suspend the insulin particles.

. Antiretroviral agents in the fusion class, such as infuvirtide (Fuzeon), inhibit HIV viral replication by: 1\. fusing the intracellular contents rendering them harmless. 2\. inhibiting the fusion of HIV positive cells to each other permitting macrophages to move in to phagocytose the positive cell. 3\. fusing the HIV positive cell with a killer T cell. 4\. inhibiting the HIV virus from fusing with a normal cell.

. The half-life of a drug is defined as: 1\. the renal clearance of the drug. 2\. the time required for half of the drug to leave the body. 3\. when the amount of drug administered matches the amount of drug excreted from the body. 4\. the time half way between doses of the medication.

Metformin (Glucophage) is administered to patients with Type II diabetes mellitus. Metformin is an example of: 1\. an antihyperglycemic agent. 2\. a hypoglycemic agent. 3\. an insulin analogue. 4\. a pancreatic alpha cell stimulant.

Which of the following facts about total parenteral nutrition (TPN) is true? 1\. It is expensive. 2\. Complications are very rare. 3\. Hospitalization is required while receiving TPN. 4\. It has few uses in modern medicine.

See all solutions

Recommended explanations on Biology Textbooks

View all explanations

What do you think about this solution?

We value your feedback to improve our textbook solutions.

Study anywhere. Anytime. Across all devices.